Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dapagliflozin on Left Ventricular Remodelling in Heart Failure with Type 2 Diabetes
2014-002742-42Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and heart failure with reduced ejection fraction (HFrEF) comparing Dapagliflozin with Placebo (2 arms). Primary endpoint: Change in left ventricular remodelling by MRI. Started Jul 2015; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on 2014-002742-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002742-42.